Works matching IS 2160763X AND DT 2024 AND VI 13 AND IP 12
Results: 11
Relative Bioavailability Studies With Mitapivat: Formulation and Food Effect Assessments in Healthy Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2024, v. 13, n. 12, p. 1271, doi. 10.1002/cpdd.1481
- By:
- Publication type:
- Article
A Bioequivalence Study of Azilsartan in Healthy Chinese Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2024, v. 13, n. 12, p. 1301, doi. 10.1002/cpdd.1479
- By:
- Publication type:
- Article
Population Pharmacokinetics Modeling and Simulation of Deutenzalutamide, A Novel Androgen Receptor Antagonist, in Patients With Metastatic Castration‐Resistant Prostate Cancer.
- Published in:
- Clinical Pharmacology in Drug Development, 2024, v. 13, n. 12, p. 1291, doi. 10.1002/cpdd.1477
- By:
- Publication type:
- Article
Bioequivalence and Pharmacokinetic Evaluation of Regorafenib Tablets in Healthy Chinese Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2024, v. 13, n. 12, p. 1317, doi. 10.1002/cpdd.1474
- By:
- Publication type:
- Article
New Ustekinumab Biosimilar Candidate FYB202: Pharmacokinetic Equivalence Demonstrated in a Randomized, Double‐Blind, Parallel‐Group, Single‐Dose Trial in Healthy Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2024, v. 13, n. 12, p. 1308, doi. 10.1002/cpdd.1473
- By:
- Publication type:
- Article
Phase 1 Evaluation of the Bioequivalence and Drug‐Drug Interaction Potential of a Novel Fixed‐Dose Combination of Ezetimibe, Atorvastatin, and Amlodipine.
- Published in:
- Clinical Pharmacology in Drug Development, 2024, v. 13, n. 12, p. 1345, doi. 10.1002/cpdd.1472
- By:
- Publication type:
- Article
A Bioequivalence Trial of Lenvatinib Mesylate Capsules in Healthy Subjects Under Fasting and Postprandial Conditions.
- Published in:
- Clinical Pharmacology in Drug Development, 2024, v. 13, n. 12, p. 1324, doi. 10.1002/cpdd.1470
- By:
- Publication type:
- Article
Bioequivalence of Meloxicam Nanocrystal Injection in Healthy Chinese Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2024, v. 13, n. 12, p. 1339, doi. 10.1002/cpdd.1467
- By:
- Publication type:
- Article
Bioequivalence and Safety of Generic Glecaprevir/Pibrentasvir Compared to a Branded Product: A Randomized, Crossover Study in Healthy Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2024, v. 13, n. 12, p. 1331, doi. 10.1002/cpdd.1463
- By:
- Publication type:
- Article
Effect of Itraconazole, a CYP3A4 Inhibitor, and Rifampin, a CYP3A4 Inducer, on the Pharmacokinetics of Vatiquinone.
- Published in:
- Clinical Pharmacology in Drug Development, 2024, v. 13, n. 12, p. 1283, doi. 10.1002/cpdd.1461
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Clinical Pharmacology in Drug Development, 2024, v. 13, n. 12, p. 1267, doi. 10.1002/cpdd.1125
- Publication type:
- Article